122 results on '"Shanker, Vicki"'
Search Results
2. Linguistic Analysis of Racial and Gender Biases in Letters of Recommendation of Neurology Residency Applicants (S33.003)
3. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells
4. Treatment of Pain in Parkinson’s Disease
5. Essential tremor : diagnosis and management
6. Anti-TIF-1α/γ Antibody-Positive Dermatomyositis Associated With Metastatic Prostatic Adenocarcinoma
7. A Telehealth Training Program for Neurology Residents (P8-2.005)
8. Reader response: Neurology residency training in 2017: A survey of preparation, perspectives, and plans
9. Dystonia
10. Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism
11. Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant
12. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects inGBAMutation Carriers
13. Diagnosis and Management of Dystonia
14. Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the G2019S Variant.
15. What’s new in dystonia?
16. Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers
17. Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations
18. Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2G2019S Variant
19. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
20. Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinsonʼs disease
21. Discordant transcriptional signatures of mitochondrial genes in Parkinson’s disease human myeloid cells
22. Cultural Disparities in Deep Brain Stimulation (DBS) Decision Making in Patients with Parkinson Disease (PD) (1713)
23. Longitudinal Assessment of Burnout In Neurology Residents (1229)
24. Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish–Mennonites
25. The EEG and Prognosis in Status Epilepticus
26. Longitudinal outcomes of LRRK2 gene mutation parkinsonism undergoing either Subthalamic Nucleus (STN) or Globus Pallidus Internus (GPi) Deep-Brain stimulation (DBS): a multi-group comparison (P1.8-029)
27. Muscle pattern changes in patients with cervical dystonia (CD) receiving botulinum toxin (BTX) (P4.8-001)
28. Non-amnestic Cognitive Impairment in Essential Tremor (ET): Defining the Phenotype (P6.057)
29. Autonomy and Praise from Co-Residents May Protect Against Burnout in Neurology Residents (P3.008)
30. PATIENTS’ PERSPECTIVE OF PHYSICANS’ COUNSELING ON EXERCISE IN PARKINSON’S DISEASE (PD) (P6.005)
31. Education in Neurology Resident Documentation Using Payroll Simulation
32. Neuropsychiatric characteristics of GBA-associated Parkinson disease
33. Case Studies in Tremor
34. Glucocerebrosidase enzyme activity in GBA mutation Parkinson’s disease
35. The Broadening Clinical Spectrum Associated with ATP1A3 Mutations (P5.397)
36. Spatial Discrimination Threshold Abnormalities are not Detected in a Pilot Study of DYT6 Dystonia Mutation Carriers
37. Clozapine Treatment for Impulse Control Disorders in Parkinson's Disease Patients: A Case Series
38. Neurology Resident Documentation Using an Electronic Medical Record (EMR) in the Outpatient Continuity Clinic and its Financial Implications (s19.001)
39. Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers
40. Treatment Options in Degenerative Cerebellar Ataxia: A Systematic Review
41. Neuropsychiatric Features of GBA-Associated Parkinson Disease (P2.024)
42. A Novel Approach to Treating Impulse Control Disorders (ICDs) in Parkinson's Disease (PD) - A Case Series (P7.086)
43. Glucocerebrosidase Enzyme Activity in GBA1 Mutation Parkinson Disease (P4.042)
44. Evaluation and Treatment of Circadian Rhythm Disorders in Parkinson's Disease (PD): Practice Patterns (P04.148)
45. Cognitive Outcomes in Glucocerebrosidase Mutation Associated Parkinson Disease (S13.005)
46. Cognitive Outcomes in Glucocerebrosidase Mutation Associated Parkinson Disease (IN2-2.004)
47. Lower cognitive performance in healthy G2019S LRRK2 mutation carriers
48. A Case of Amiodarone-Associated Myoclonus Responsive to Levetiracetam
49. LRRK2G2019S mutations are associated with an increased cancer risk in Parkinson disease
50. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.